β受体基因多态性与高血压及β阻滞剂降压疗效相关性研究进展
被引量:2
摘要
原发性高血压是与心脑血管事件发病率及死亡率增加密切相关的一种常见疾病,但目前即使在美国也仅有约1/3的患者有效地控制了其血压水平,个体对药物治疗反应的可变性和不可预见性是高血压控制率较低的重要原因之一。随着分子生物学技术的飞速发展,我们期望能从基因水平揭示高血压发病机制,同时对不同降压药物的疗效进行遗传多态性预测分析并用于指导临床用药实践。
出处
《中国医药导刊》
2007年第1期27-29,共3页
Chinese Journal of Medicinal Guide
参考文献27
-
1Donna K.Arnett,Steven A.Claas. Pharmacogenetics of antihypertensive treatment. Drug Dev Res, 2004; 62:191-199
-
2梁宇,赵彦艳,刘洪,时景璞.β肾上腺素能受体基因家族在中国东北高血压病高发人群中的基因型分析[J].中华医学遗传学杂志,2004,21(2):124-127. 被引量:19
-
3Shioji K, Kokubo Y, Mannami T, et al. Association between hypertension and the alpha-adducin, beta1-adrenoreceptor and Gprotein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res, 2004, 27:31-37
-
4Kristina Bengtsson, Olle Melander, Marju Orho-Melander, et al.Polymorphism in the β1-Adrenergic receptor gene and hypertension.Circulation, 2001; 104:187-190
-
5Wagoner LE, Craft LL, Zengel P, et al.Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J, 2002; 144:840-846
-
6White HL,Maqbool A,McMahon AD,et al.An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. European heart journal,2002; 23: 1087-92
-
7Johnson JA, Zineh I, Puckett BJ,et al. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther, 2003; 74:44-52
-
8Sofowora GG, Dishy V, Muszkat M,et al.A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther, 2003; 73:366-71
-
9Liu J,Liu ZQ,Tan ZR,et al. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Phatmacol Ther, 2003; 74:372-9
-
10Liu J, Liu ZQ, Yu BN, et al. Beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Phatmacol Ther. 2006; 80:23-32
二级参考文献13
-
1Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM,eds. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1990.81-100.
-
2Tonolo G, Melis MG, Secchi G, et al. Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population.J Hypertens, 1999, 17∶33-38.
-
3Bengtsson K, Melander O, Orho-Melander M, et al. Polymorphism in the β1-adrenergic receptor gene and hypertension. Circulation, 2001, 104∶187-190.
-
4Maqbool A, Hall AS, Ball SG, et al. Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay. Lancet, 1999, 353∶897.
-
5Svetkey LP, Timmons PZ, Emovon O, et al. Association of hypertension with β2- and α2c 10-adrenergic receptor genotype. Hypertension, 1996, 27∶1210-1215.
-
6Timmermann B, Mo R, Luft FC, et al. β2-adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen blood pressure study. Kidney Int, 1998, 53∶1455-1460.
-
7Aynacioglu AS, Cascorbi I, Gungor K, et al. Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the β2-adrenergic receptor among Turks. Br J Clin Pharmacol, 1999, 48∶761-764.
-
8Rissanen J, Kuopusjarvi J, Pihlajamaki J, et al. The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene. Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care, 1997, 20∶1319-1323.
-
9Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet, 1995, 59∶97-105.
-
10Kotanko P, Binder A, Tasker J, et al. Essential hypertension in African Caribbeans associates with a variant of the β2-adrenoceptor. Hypertension, 1997, 30∶773-776.
共引文献18
-
1郭艳英,赵蕾,王坤,沙根德克.耶里节夫,何秉贤.β3肾上腺素能受体基因多态性与新疆哈萨克族人群高血压病的相关研究[J].国际遗传学杂志,2006,29(6):476-477. 被引量:2
-
2刘克坚,李南方.β_2肾上腺素能受体基因+46、+79位多态性与血脂水平关系研究进展[J].兵团医学,2008(2):50-52.
-
3骆秦,李南方.β_2-肾上腺素能受体基因多态性与高血压关系的研究进展[J].国外医学(遗传学分册),2005,28(5):277-280. 被引量:1
-
4王红梅,李南方.β_3肾上腺素能受体基因多态性与原发性高血压相关性研究现状[J].临床心血管病杂志,2006,22(10):637-639. 被引量:1
-
5Rile Hu,Rile Hu,Shigang Zhao,Guangming Niu,Chunyu Zhang,Zhiguang Wang,Mingfang Jiang.Association between essential hypertension and polymorphisms of beta 1 adrenergic receptor gene G1165C (Gly389Arg) in Chinese Mongolian population[J].Neural Regeneration Research,2006,1(3):226-229. 被引量:2
-
6徐翀,敖由特,宋涛,格尔丽,吴玛,陈永红.β3肾上腺素能受体基因多态与新疆[J].新疆医学,2006,36(5):58-59. 被引量:1
-
7王红梅,李南方.β2肾上腺素能受体基因多态性与高血压相关关系的研究进展[J].医学综述,2006,12(21):1281-1283. 被引量:2
-
8潘慧娟,郭艳英,王坤,赵蕾,何秉贤.PPAR-γ2基因和β3-AR基因联合变异与新疆哈萨克族人群高血压病的关系[J].中国优生与遗传杂志,2007,15(3):19-21. 被引量:5
-
9王红梅,李南方.β3肾上腺素能受体基因多态性与胰岛素抵抗、高血压病关系的研究进展[J].国际遗传学杂志,2007,30(2):140-142. 被引量:4
-
10宋艳丽,吴先正,郭刚,张海霞,杨奕清.β1肾上腺素能受体基因389A/G多态性与急性心肌梗死的关系[J].中华医学遗传学杂志,2007,24(4):422-424. 被引量:3
同被引文献12
-
1王鲁雁,孙宁玲,闫征.血管紧张素Ⅱ1型受体基因多态性与高血压患者伊贝沙坦降压疗效的关系[J].北京大学学报(医学版),2004,36(3):330-332. 被引量:2
-
2俞良.硝酸甘油复合美托洛尔在鼻内窥镜术控制性降压中的应用[J].浙江临床医学,2005,7(11):1210-1210. 被引量:1
-
3刘长云,周建光,黄亚莉,方以群.血管紧张素转换酶基因多态性与高血压的关系[J].中华航海医学与高气压医学杂志,2006,13(5):290-291. 被引量:5
-
4唐强,刘海玲,刘昭前.抗高血压药物的基因组学研究进展[J].中南药学,2007,5(2):157-160. 被引量:9
-
5TROTTA R,DONATI M B,IACOVIELLO L. Trends in pharmacogenomics of drugs acting on hypertension [ J ]. Pharmacological Research, 2004,49 (4) : 351 - 356.
-
6SCHELLEMAN H, KLUNGEL O H, VAN DULJN C M, et al. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy [ J ]. Ann Phar, 2006,40 ( 2 ) : 212 - 218.
-
7JONES A, DHAMRAIT S S, PAYNE J R, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension [ J ]. Hypertension, 2007,42 ( 4 ) : 500 - 506.
-
8陈新谦 金有预.新编药物学[M].北京:人民卫生出版社,1993.306.
-
9Hersey S L,Dell N E,Lowe S,et al, Nieardipine Versus Nitroprusside for Controlled Hypotension During Spinal in Adolescent[J]. Anesth Analg, 1997,84 : 1239-1244
-
10Lopez Herce J, Borrego R, Bustinza A, et ah Elevated Carboxyhemoglobin Associated with Sodium Nitroprusside Treatment [J]. Intensive Care Med,2005,31(9) :1235-1238.
引证文献2
-
1胡衍辉,徐国海,周志东,卢忆梅,董莉萍.硝普钠复合美托洛尔控制性降压用于鼻窦内窥镜手术的研究[J].江西医学院学报,2008,48(3):61-62. 被引量:1
-
2赵钢涛,王金萍,杨凡,边佳明,许景峰.基因芯片检测方法检测抗高血压药物相关基因20例[J].医药导报,2008,27(12):1518-1521. 被引量:4
二级引证文献5
-
1杨凡,赵钢涛,丁媛媛,边佳明,肖乐东,许景峰.基因芯片法检测抗高血压药物相关基因多态性[J].东南国防医药,2010,12(5):397-400. 被引量:1
-
2周慧,汤纳平,马璟.药物代谢酶遗传多态性对药物神经毒性的影响[J].中国新药杂志,2012,21(9):975-979.
-
3廖丽芳.鼻窦内窥镜手术麻醉管理总结[J].临床医药文献电子杂志,2020,7(33):27-27. 被引量:1
-
4张乐晶,杨全中,王亚娟,程远芳,胡雨薇.利用Taqman探针熔解曲线技术检测抗高血压药物相关基因多态位点[J].药物分析杂志,2021,41(8):1428-1435. 被引量:1
-
5俞佳利,项彦琳,薛金贵.血管紧张素转换酶I/D基因多态性与原发性高血压关系的研究进展[J].中西医结合心脑血管病杂志,2024,22(17):3161-3163.
-
1傅国辉,王孝铭.家兔心肌细胞膜β肾上腺素能受体在心肌缺血/再灌注损伤时的变化[J].哈尔滨医科大学学报,1991,25(5):315-318.
-
2马文珠,陈兆和.扩张型心肌病β肾上腺素能受体的变化[J].中华内科杂志,1991,30(9):554-556. 被引量:7
-
3王彤,黄子通,吴海东,符岳,林小鸿,常瑞明,杨柳青,杨鹰.电刺激致猪心室颤动及心肺复苏过程中β肾上腺素能受体变化规律的研究[J].岭南急诊医学杂志,2005,10(4):241-243. 被引量:1
-
4丁荣华,黄峻,黄元铸,马文珠,王敬良.扩张型心肌病患者外周血淋巴细胞β肾上腺素能受体的变化[J].临床心血管病杂志,1998,14(3):137-139. 被引量:3
-
5汪翼,郭锋.小儿常见心脏猝死与急救[J].中国社区医师,2012,28(40):17-17. 被引量:1
-
6杨雪媛,吴新民,朱姜华.倍他乐克对非心脏手术患者围术期外周血淋巴细胞β-AR基因表达的影响[J].中国分子心脏病学杂志,2009,9(4):209-214.
-
7陆红进,陈惠平,夏继辉,王露,夏文胜,申仕海.老年高血压临床特征及治疗对策[J].中国民族民间医药,2010,19(24):160-160. 被引量:4
-
8韩勤甫,贾银明,王中,余景丽.美托洛尔对OMI患者心率变异性的影响及对心律失常的治疗作用[J].中国慢性病预防与控制,2001,9(1):6-7.
-
9李果,夏锋,吴林,姚超,钱程,别平.β肾上腺素能受体兴奋对大鼠急性肝损伤的影响[J].第三军医大学学报,2012,34(9):809-812. 被引量:2
-
10宋晓东,辛颖,刘哲,张禅那,惠汝太.β肾上腺素能受体在心力衰竭中的作用[J].齐鲁医学杂志,2007,22(3):278-279.